Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracelluar signal-regulated kinase 1/2 signaling pathways

Molecular Endocrinology

Volumn 18, Issue 6, 2004, Pages 1533-1545

  Sales, Kurt J ^a   Maudsley, Stuart ^a   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; RECEPTOR SUBTYPE; RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA TRANSFECTION; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; INCUBATION TIME; ONCOGENE SRC; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CYCLIC AMP; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2542438557     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0022     Document Type: Article

References (50)

1. Baird DT, Cameron ST, Critchley HO, Drudy TA, Howe A, Jones RL, Lea RG, Kelly RW 1996 Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 70: 15-17
2. Kniss DA 1999 Cyclooxygenases in reproductive medicine and biology. J Soc Gynaecol Investig 6:285-292
3. Sales KJ, Jabbour HN 2003 Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 71:97-117
4. Dong YL, Gangula PR, Fang L, Yallampalli C 1996 Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins 52:13-34
5. Sheng H, Shao J, Washington MK, DuBois RN 2001 Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081
6. Tsujii M, Kawano S, DuBois RN 1997 Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336-3340
7. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716
8. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL 2002 COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931
9. Jabbour HN, Milne SA, Williams ARW, Anderson RA, Boddy SC 2001 Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 85:1023-1031
10. Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, Millar RP, Jabbour HN 2001 Cyclooxygenase-2 expression and prostaglandin E2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 86:2243-2249
11. Coleman RA, Smith WL, Narumiya S 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229
12. Ashby B 1998 Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling. Biochem Pharmacol 55:239-246
13. Fujino H, West KA, Regan JW 2002 Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 277:2614-2619
14. Narumiya S, Sugimoto Y, Ushikubi F 1999 Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226
15. Sugimoto Y, Negishi M, Hayashi Y, Namba T, Honda A, Watabe A, Hirata M, Narumiya S, Ichikawa A 1993 Two isoforms of the EP3 receptor with different carboxylterminal domains. Identical ligand binding properties and different coupling properties with Gi proteins. J Biol Chem 268:2712-2718
16. Regan JW 2003 EP2 and EP4 prostanoid receptor signaling. Life Sci 74:143-153
17. Buchanan FG, Wang D, Bargiacchi F, DuBois RN 2003 Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457
18. Eibl G, Bruemmer D, Okada Y, Duffy JP, Law RE, Reber HA, Hines OJ 2003 PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochem Biophys Res Commun 306:887-897
19. Seno H, Oshima M, Ishikawa T, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM 2002 Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in APC δ 716 mouse intestinal polyps. Cancer Res 62:506-511
20. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC δ 714 knockout mice. Nat Med 7:1048-1051
21. Fujino H, Regan JW 2003 Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 24:335-340
22. Fujino H, Xu W, Regan JW 2003 Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 278:12151-12156
23. Resnick MB, Gallinger S, Wang HH, Odze RD 1995 Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis. Cancer 76:187-194
24. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS 2002 Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293
25. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN 2002 Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, PGE receptors and angiogenic factors by cyclooxygenase-1. Cancer Res 62:424-432
26. Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK 2000 Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-δ in human endometrial adenocarcinoma. Neoplasia 2:483-490
27. Smith SK, Abel MH, Kelly RW, Baird DT 1981 Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88:434-442
28. Hofmann GE, Rao CV, Barrows GH, Sanfilippo JS 1983 Topography of human uterine prostaglandin E and F2 α receptors and their profiles during pathological states. J Clin Endocrinol Metab 57:360-366
29. Adelantado JM, Rees MC, Lopez Bernal A, Turnbull AC 1988 Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 95:162-165
30. Perchick GB, Jabbour HN 2003 COX-2 overexpression inhibits cathepsin D mediated cleavage of plasminogen to the potent anti-angiogenic factor angiostatin. Endocrinology 144:5322-5328
31. Lowes VL, Ip NY, Wong YH 2002 Integration of signals from receptor tyrosine kinases and g protein-coupled receptors. Neurosignals 11:5-19
32. Luttrell LM, Daaka Y, Lefkowitz RJ 1999 Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11:177-183
33. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A 2001 Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594-1600
34. Gschwind A, Prenzel N, Ullrich A 2002 Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62:6329-6336
35. Pai R, Nakamura T, Moon WS, Tarnawski AS 2003 Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17:1640-1647
36. Hackel PO, Zwick E, Prenzel N, Ullrich A 1999 Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11:184-189
37. Pierce KL, Luttrell LM, Lefkowitz RJ 2001 New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-1539
38. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, Daaka Y, Lefkowitz RJ, Luttrell LM 2000 The β-2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275:9572-9580
39. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272
40. Salazar EP, Rozengurt E 1999 Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J Biol Chem 274:28371-28378
41. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T 1998 Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896
42. Wells A 1999 EGF receptor. Int J Biochem Cell Biol 31:637-643
43. Lewis TS, Shapiro PS, Ahn NG 1998 Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139
44. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494
45. Jain RK, Booth MF 2003 What brings pericytes to tumor vessels? J Clin Invest 112:1134-1136
46. Scambia G, Benedetti Panici P, Ferrandina G, Battaglia F, Distefano M, D'Andrea G, De Vincenzo R, Maneschi F, Ranelletti FO, Mancuso S 1994 Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer 56:26-30
47. Niikura H, Sasano H, Matsunaga G, Watanabe K, Ito K, Sato S, Yajima A 1995 Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. Hum Pathol 26:892-896
48. Kedar D, Baker CH, Killion JJ, Dinney CP, Fidler IJ 2002 Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 8:3592-3600
49. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM 2000 Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024-1028
50. Milne SA, Perchick GB, Boddy SC, Jabbour HN 2001 Expression, localization, and signalling of PGE2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 86:4453-4459